1/27/2022 6:03:26 AM
Danaher Q4 EPS $2.39; Non-GAAP EPS $2.69
1/11/2022 6:32:25 AM
Danaher Expects Q4 Core Revenue Growth To Be Above Prior Guidance
12/7/2021 4:18:27 PM
Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.21, Record Date 12/30/2021
12/7/2021 4:17:37 PM
Danaher Declares Dividend Of $0.21, Payable Jan. 28/record Dec. 30
12/1/2021 9:50:33 PM
Danaher Prices Offering Of $1 Bln Principal Amount Of 2.800% Senior Notes Due 2051
11/29/2021 7:01:58 AM
Danaher To Redeem All Of EUR 800 Mln Aggregate Principal Amount Of 2.500% Senior Notes Due 2025
10/21/2021 6:02:04 AM
Danaher Q3 Adj. EPS From Cont. Ops. $2.39, Consensus $2.15
9/14/2021 4:19:06 PM
Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.21, Record Date 9/30/2021
9/14/2021 4:18:22 PM
Danaher Declares Quarterly Dividend Of $0.21/share, Payable Oct. 29/ Record Sept. 30
8/30/2021 4:18:28 PM
Danaher Completes Acquisition Of Aldevron
8/24/2021 8:32:05 AM
Danaher Says Effective April 1, 2022, Georgeann Couchara To Succeed Angela Lalor As SVP, Human Resources
8/20/2021 8:02:52 AM
Former Danaher President & CEO George Sherman Passes Away Earlier This Week After Illness
7/27/2021 2:45:46 AM
Cytiva And Pall Corp Investing $1.5 Bln Over Two Years; Plan To Hire 2000 Full-time Associates
7/26/2021 8:33:19 AM
Beckman Coulter To Take Over Distribution To Customers Of B-type Natriuretic Peptide Assay